Aspire Private Capital’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-800
| Closed | -$1.53K | – | 507 |
|
|
2024
Q3 | $1.53K | Hold |
800
| – | – | ﹤0.01% | 567 |
|
|
2024
Q2 | $1.57K | Hold |
800
| – | – | ﹤0.01% | 570 |
|
|
2024
Q1 | $1.9K | Hold |
800
| – | – | ﹤0.01% | 585 |
|
|
2023
Q4 | $1.73K | Hold |
800
| – | – | ﹤0.01% | 573 |
|
|
2023
Q3 | $1.68K | Hold |
800
| – | – | ﹤0.01% | 575 |
|
|
2023
Q2 | $2.29K | Hold |
800
| – | – | ﹤0.01% | 531 |
|
|
2023
Q1 | $2.33K | Hold |
800
| – | – | ﹤0.01% | 526 |
|
|
2022
Q4 | $2.34K | Hold |
800
| – | – | ﹤0.01% | 513 |
|
|
2022
Q3 | $2K | Hold |
800
| – | – | ﹤0.01% | 524 |
|
|
2022
Q2 | $2K | Hold |
800
| – | – | ﹤0.01% | 505 |
|
|
2022
Q1 | $2K | Hold |
800
| – | – | ﹤0.01% | 510 |
|
|
2021
Q4 | $2K | Buy |
800
+400
| +100% | +$1K | ﹤0.01% | 537 |
|
|
2021
Q3 | $1K | Buy |
+400
| New | +$1K | ﹤0.01% | 562 |
|